BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
BioInvent International Cash from Operations (TTM): -31.06M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -31.06M |
| December 31, 2023 | -32.27M |
| September 30, 2023 | -31.98M |
| June 30, 2023 | -5.083M |
| March 31, 2023 | -3.117M |
| December 31, 2022 | -4.110M |
| September 30, 2022 | -6.124M |
| June 30, 2022 | -29.87M |
| March 31, 2022 | -31.37M |
| December 31, 2021 | -28.72M |
| September 30, 2021 | -16.16M |
| June 30, 2021 | -13.98M |
| March 31, 2021 | -9.178M |
| December 31, 2020 | -6.840M |
| September 30, 2020 | -13.40M |
| June 30, 2020 | -11.71M |
| March 31, 2020 | -12.50M |
| December 31, 2019 | -13.28M |
| September 30, 2019 | -14.94M |
| June 30, 2019 | -16.40M |
| March 31, 2019 | -17.05M |
| December 31, 2018 | -16.29M |
| September 30, 2018 | -13.92M |
| June 30, 2018 | -13.54M |
| March 31, 2018 | -11.77M |
| Date | Value |
|---|---|
| December 31, 2017 | -8.904M |
| September 30, 2017 | -9.251M |
| June 30, 2017 | -8.576M |
| March 31, 2017 | -9.464M |
| December 31, 2016 | -8.431M |
| September 30, 2016 | -7.033M |
| June 30, 2016 | -5.571M |
| March 31, 2016 | -5.916M |
| December 31, 2015 | -8.609M |
| September 30, 2015 | -11.07M |
| June 30, 2015 | -9.860M |
| March 31, 2015 | -9.964M |
| December 31, 2014 | -11.13M |
| September 30, 2014 | -3.654M |
| June 30, 2014 | -6.436M |
| March 31, 2014 | -8.386M |
| December 31, 2013 | -8.395M |
| September 30, 2013 | -19.84M |
| June 30, 2013 | -22.24M |
| March 31, 2013 | -23.42M |
| December 31, 2012 | -25.18M |
| September 30, 2012 | -23.87M |
| June 30, 2012 | -24.37M |
| March 31, 2012 | -8.422M |
| December 31, 2011 | -8.554M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-32.27M
Minimum
Dec 2023
-3.117M
Maximum
Mar 2023
-16.60M
Average
-13.69M
Median
Cash from Operations (TTM) Benchmarks
| Abliva AB | -2.578M |
| Karolinska Development AB | -2.114M |
| Calliditas Therapeutics AB | -37.91M |
| Oncopeptides AB | -30.00M |
| Olink Holding AB | -42.12M |